Home Data Calendar Blog

RLAY

Tables

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Common Stock Value		0.12	0.11	0.11	0.11	NA	NA	NA
Weighted Average Number Of Diluted Shares Outstanding		110.91	NA	NA	NA	92.69	NA	NA
Weighted Average Number Of Shares Outstanding Basic		110.91	NA	NA	NA	92.69	NA	NA
Weighted Average Number Of Share Outstanding Basic And Diluted		NA	108.64	108.29	NA	92.69	91.94	90.20
Earnings Per Share Basic		-0.76	NA	NA	NA	-0.66	NA	NA
Earnings Per Share Diluted		-0.76	NA	NA	NA	-0.66	NA	NA
Earnings Per Share Basic And Diluted		NA	-0.71	-0.57	-0.62	-0.66	-2.10	-0.47

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Revenue From Contract With Customer Excluding Assessed Tax		0.34	0.36	0.42	0.57	0.67	0.84	0.95
Revenues		0.34	0.36	0.42	27.83	0.67	0.84	0.95
Operating Expenses		86.24	78.18	63.14	68.29	61.66	194.42	43.36
Research And Development Expense Excluding Acquired In Process Cost		66.90	60.51	51.67	51.91	44.97	45.15	30.62
General And Administrative Expense		16.07	17.46	16.07	15.55	14.68	14.42	12.73
Operating Income Loss		-85.89	-77.81	-62.72	-67.72	-60.99	-193.58	-42.41
Allocated Share Based Compensation Expense		13.72	15.15	13.46	10.22	12.42	16.15	9.67
Other Comprehensive Income Loss Net Of Tax		-1.48	-2.69	-8.13	-1.10	0.07	-0.08	-0.05
Net Income Loss		-84.17	-76.79	-62.05	-67.46	-60.83	-193.40	-42.18
Comprehensive Income Net Of Tax		-85.66	-79.48	-70.18	-68.55	-60.76	-193.47	-42.24

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Assets		1168.72	889.42	949.88	1008.44	671.62	714.40	771.35
Liabilities		168.95	109.78	107.91	110.64	100.53	95.87	38.56
Liabilities And Stockholders Equity		1168.72	889.42	949.88	1008.44	671.62	714.40	771.35
Stockholders Equity		999.77	779.64	841.97	897.81	571.09	618.53	732.79

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Assets Current		1087.30	855.79	915.79	976.24	639.26	681.28	742.43
Cash And Cash Equivalents At Carrying Value		354.64	107.74	119.44	280.12	228.56	260.07	262.72
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		357.22	110.31	122.02	282.70	231.14	262.65	263.60
Accounts Receivable Net Current		0.24	0.29	0.27	0.40	0.80	0.28	NA
Other Assets Current		11.58	NA	NA	1.76	NA	NA	NA
Prepaid Expense And Other Assets Current		NA	12.75	12.66	13.23	17.70	5.58	7.75
Available For Sale Securities Debt Securities		699.15	730.25	778.73	677.95	387.95	411.15	463.36

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Property Plant And Equipment Net		11.39	8.92	8.90	6.54	6.24	6.56	5.91

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Liabilities Current		71.43	43.90	41.69	24.32	28.52	25.39	16.08
Accounts Payable Current		9.48	4.30	8.05	8.28	6.32	7.87	5.59
Accrued Liabilities Current		29.36	22.11	15.22	13.95	20.10	15.40	8.87
Other Liabilities Current		26.90	15.41	16.33	0.40	NA	NA	NA
Contract With Customer Liability Current		NA	0.08	0.17	0.25	0.33	0.41	NA

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Operating Lease Liability Noncurrent		54.60	20.02	20.55	21.06	21.55	22.02	22.48

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Stockholders Equity		999.77	779.64	841.97	897.81	571.09	618.53	732.79
Common Stock Value		0.12	0.11	0.11	0.11	NA	NA	NA
Additional Paid In Capital		2004.14	1698.37	1681.22	1666.89	1271.63	1258.31	1179.10
Retained Earnings Accumulated Deficit		-991.11	-906.93	-830.15	-768.10	-700.64	-639.81	-446.41
Accumulated Other Comprehensive Income Loss Net Of Tax		-13.39	-11.91	-9.22	-1.09	0.01	-0.06	0.01
Stock Issued During Period Value New Issues		284.74	NA	NA	NA	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		13.72	15.15	13.46	NA	12.42	16.15	9.67

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Operating Activities		-66.14	-57.09	-49.17	-39.71	-53.20	-28.14	46.64
Net Cash Provided By Used In Investing Activities		27.19	43.39	-112.38	-292.75	20.79	26.07	-233.62
Net Cash Provided By Used In Financing Activities		285.87	2.00	0.88	384.01	0.90	1.12	2.06

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Operating Activities		-66.14	-57.09	-49.17	-39.71	-53.20	-28.14	46.64
Net Income Loss		-84.17	-76.79	-62.05	-67.46	-60.83	-193.40	-42.18
Increase Decrease In Accounts Receivable		-0.05	0.02	-0.13	-0.40	0.53	0.20	-75.00
Increase Decrease In Accounts Payable		4.63	-3.39	-1.22	2.43	-0.64	-0.06	-0.81
Share Based Compensation		13.72	15.15	13.46	10.22	12.42	16.15	9.67

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Investing Activities		27.19	43.39	-112.38	-292.75	20.79	26.07	-233.62
Payments To Acquire Property Plant And Equipment		2.10	1.86	2.79	0.88	1.74	0.38	0.48
Payments To Acquire Investments		55.83	24.25	127.69	327.03	7.39	26.92	619.32

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Financing Activities		285.87	2.00	0.88	384.01	0.90	1.12	2.06

		2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Revenues		0.34	0.36	0.42	27.83	0.67	0.84	0.95
Revenue From Contract With Customer Excluding Assessed Tax		0.34	0.36	0.42	0.57	0.67	0.84	0.95
Genentech Inc, License		0.30	0.30	NA	NA	0.40	0.80	NA

Plots across concepts

Line plots across dimensions of each concept